08.12.2026, 16:00–17:00MünchenOnline

English Tutorial: US Reimbursement Strategy – Getting Paid After FDA

Kurz zusammengefasst

This introductory tutorial provides European MedTech founders with a high-level roadmap for entering the US market. The session is designed to help startups understand the major components of the US commercialization journey, including the regulatory landscape, reimbursement ecosystem, market access considerations, and foundational activities that should begin early, such as intellectual property strategy, quality systems, and market validation.

Auf Basis der Veranstaltungsbeschreibung.

Auf einen Blick

Datum
Zeit
Ort
Online
Format
Online

Teilnahme

Anmeldung und aktuelle Teilnahmebedingungen stehen auf der Veranstaltungsseite.

Das erwartet dich

By establishing this framework upfront, the tutorial prepares founders for the deeper topics that will be explored throughout the remainder of the series and helps them understand how critical business, regulatory, and commercial decisions intersect during US expansion.

The experts of EmeraNova provide an overview and practical guidance on the following topics:

Opening & Context

Building on the FDA overview in the first tutorial, this session addresses the second major hurdle to US commercialization: reimbursement. FDA clearance or approval does not guarantee that a product will be paid for or purchased. The tutorial explains how US coding, coverage, and payment work and what they mean for pricing, customers, adoption, and investment, including how US hospitals and physicians decide whether to buy. Through a real-world wound care case study and interactive activities, founders leave with a clearer view of the reimbursement strategy for their own technology.

The experts of EmeraNova (formerly BioLab Holdings) provide an overview and practical guidance on the following topics:

Opening & Recap

Introduction to EmeraNova and Catalyst Recap of the first tutorial and why reimbursement is the second hurdle to US market entry

How the US Pays

Germany vs. the US at a glance Who pays: Medicare, Medicaid, and private payers The three pillars of reimbursement: coding, coverage, and payment How site of service drives payment

Coding, Coverage & Payment in Practice

Securing codes and coverage from Medicare and private payers Faster paths for innovative devices How payment sets the ceiling on price

The Buyer’s Perspective

Hospital and physician economics: why coverage alone does not drive adoption Case study: skin substitutes and the 2026 payment shift

Clinical Evidence for FDA vs. Payers

Designing one evidence plan for regulators, payers, and buyers

Building Your Reimbursement Strategy

Reimbursement readiness timeline Reimbursement Strategy…

Häufige Fragen

Wann findet English Tutorial: US Reimbursement Strategy – Getting Paid After FDA statt?

Am Dienstag, 08.12.2026, 16:00–17:00 Uhr.

Findet English Tutorial: US Reimbursement Strategy – Getting Paid After FDA online statt?

Die Veranstaltung findet online statt. Die Zugangsdaten erhalten Sie über die Veranstaltungsseite.

Wie kann ich mich für English Tutorial: US Reimbursement Strategy – Getting Paid After FDA anmelden?

Die Anmeldung erfolgt über die Veranstaltungsseite. Dort stehen auch die aktuellen Teilnahmebedingungen.

Am selben Tag

Rund um den Termin

Quelle & Transparenz

Angaben stammen von Munich Startup.

Alle Angaben ohne Gewähr. Termine, Preise und Teilnahmebedingungen bitte beim Veranstalter prüfen.

Fehler melden

Mehr entdecken